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Since  the  publication  of  the  complete  human  genome 
sequence in 2003, hundreds of genome-wide association 
studies  (GWAS)  have  been  carried  out  in  the  human 
population  to  identify  polymorphisms  associated  with 
human  disease  [1,2].  As  more  genome  sequences  are 
published,  including  those  of  many  important  human 
patho  gens, there is an expectation that GWAS will also 
provide insights into the evolution of pathogen virulence 
or drug resistance.
In a recent study published in BMC Genetics, Orjuela-
Sanchéz et al. [3] present an assessment of the feasibility 
of  future  GWAS  in  the  malaria  parasite  Plasmodium 
vivax.  They  analyzed  a  100-kb  chromosome  segment 
(0.4%  of  the  parasite  genome)  in  field  samples  of  the 
parasite from South America and Asia with the aim of 
determining  the  genetic  diversity  in  these  populations 
and to look for geographical effects. The authors found 
that  the  Brazilian  vivax  population  they  studied  was 
amenable to future GWAS as it contained high levels of 
genetic  diversity  -  a  prerequisite  for  distinguishing  the 
areas  of  the  parasite  genome  associated  with  traits  of 
interest. They also confirmed that it exhibits appropriate 
levels  of  linkage  disequilibrium  -  the  non-random 
association of specific genetic markers with the trait of 
interest, indicating that the marker is in or near a gene 
that underlies that trait. Too little linkage disequilibrium 
means that a genetic marker is unlikely to stay associated 
with the gene that causes the trait of interest; too much 
and there is a risk of ‘false positives’ where the marker 
appears correlated with a trait of interest but is actually 
far away from the gene that governs it. The authors raise 
several notes of caution, however, not least the fact that 
substantial  geographical  substructuring  exists  in  vivax 
populations, which could confound efforts to find true 
associations  between  markers  and  traits.  The  authors 
rightly emphasize the need for careful correction for geo-
graphical population structure; however, the structuring 
that they observed among the Brazilian isolates showed 
no clear relationship with collection site - suggesting that 
these issues may not be easily resolved by geographical 
corrections alone.
What makes a good subject for GWAS?
The  first  and  fundamental  consideration  in  planning  a 
GWAS is how much the trait of interest is likely to be 
influenced by genetics at all. In the case of a trait such as 
virulence, it may be that the host’s genetics are far more 
important than the parasite’s, and looking at the parasite 
genome is not going to turn up a useful result. A recent 
paper by Anderson et al. [4] considers how to approach 
this  issue  in  another  malaria  parasite,  Plasmodium 
falciparum. Here, the authors used microsatellite analysis 
to determine the relatedness between parasites obtained 
from  185  patients.  Microsatellite  analysis  is  cheap  and 
quick, as appreciated by any daytime TV viewer who has 
seen  it  used  for  talk-show  paternity  tests.  If  parasite 
relatedness correlates with a trait, then parasite genetics 
are likely to be important in governing that trait. They 
found that parasite relatedness was correlated with drug 
resistance, but that the rate of parasite clearance follow-
ing artemisinin-based combination therapies was not.
Once a trait is identified as having a strong genetic link, 
we may be justified in conducting a GWAS to look for the 
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presents another problem - this time, statistical. It is well 
recognized that when processing such large datasets as 
provided by GWAS, performing many tests looking for 
associations, there is the high possibility of obtaining an 
apparently significant association purely by chance. The 
great  evolutionary  biologist  John  Maynard  Smith  once 
said: ‘statistics is the science that lets you do 20 experi-
ments a year and publish one false result in Nature’. There 
are  statistical  means  for  correcting  for  multiple  com-
parisons - for example, the Bonferroni correction - but 
these are so stringent that they make it hard to find any 
effects at all. There is no simple solution to this problem 
[5];  ultimately  we  have  to  rely  on  the  judgement  of 
informed scientists concerning the nature of the genes 
identified by the analysis. Perhaps this all illustrates that, 
fortunately, there is no immediate possibility of science 
being  conducted  by  robots  chucking  things  into 
sequencers and computer programs analyzing the data 
and emailing the results to big Pharma.
A third issue to be overcome if a GWAS is to give useful 
results is the choice of the genetic markers themselves. 
These  markers  are  single  nucleotide  polymorphisms 
(SNPs),  and  it  is  vital  to  choose  the  correct  set  of 
reference SNPs for the question of interest. The older the 
mutation governing a trait, or the lower the degree of 
linkage  disequilibrium  in  a  population,  the  higher  the 
density of SNPs required. In malaria parasites, the ratio 
of self-fertilizing to cross-fertilizing reproductive events 
is extremely variable in different malaria parasite popu  la-
tions, and is affected by natural selection. This compli-
cates  assumptions  about  linkage  disequilibrium  across 
different parts of the genome and increases the density of 
SNPs required for successful association mapping.
The crucial importance of choosing the correct set of 
reference SNPs in a GWAS is well illustrated by efforts to 
explore human genes that influence malaria susceptibility. 
The mutation responsible for sickle-cell anemia (a point 
mutation  at  the  beta-globin  locus)  is  known  to  offer 
substantial  protection  against  severe  malaria  (for  a 
review, see [6]). Jallow et al. [7] conducted a GWAS of 
severe malaria in Gambian children, and used the sickle-
cell  mutation  as  a  benchmark  to  detect  the  success  of 
different GWAS methods. When a reference sample from 
a non-Gambian African population (the Yoruba HapMap 
sample) was used to analyze the Gambian data, no signal 
could  be  detected  for  the  sickle-cell  mutation  (even 
though at a macroscopic level the Yoruba and Gambian 
patterns  of  linkage  disequilibrium  appeared  similar). 
Choosing  the  wrong  set  of  reference  SNPs  therefore 
presents a huge potential pitfall for GWAS.
The  study  by  Orjuela-Sanchéz  et  al.  [3]  hints  at  the 
possibility of conserved recombination hotspots within 
P.  vivax;  such  hotspots,  as  they  note,  have  also  been 
observed  in  Plasmodium  falciparum  [8].  The  identifi-
cation  and  confirmation  of  hotspots  will  play  an 
important  part  in  the  design  and  analysis  of  future 
GWAS in both of these malaria parasites.
GWAS in Plasmodium
The very first Plasmodium GWAS was published by Mu 
et al. [9] in December 2009. The authors analyzed 189 
P.  falciparum  isolates  from  Asia  (146  isolates),  Africa 
(26  isolates),  America  (14  isolates)  and  Papua  New 
Guinea (3 isolates), and conducted a GWAS looking for 
genes associated with drug resistance. They were able to 
identify a gene (PFA0665w) that had not previously been 
associated with the parasite response to antimalarials. As 
discussed  earlier,  drug  resistance  seems  to  be  a  trait 
largely governed by parasite genetics and is thus clearly 
an  area  where  parasite  GWAS  may  continue  to  prove 
helpful. However, as noted by Orjuela-Sanchéz et al. [3], 
gene  copy  number  variation  (CNV)  can  contribute  to 
drug-resistance  phenotypes  in  addition  to  point 
mutation. Future GWAS in malaria parasites will need to 
take CNV into account, and methods are being developed 
to make this possible [10].
Orjuela-Sanchéz et al. [3] make two additional points 
of broad interest for the GWAS field and beyond. For 
P. falciparum, geographical regions of high transmission 
have  greater  genetic  diversity  than  regions  with  low 
trans  mission [11,12]. We expect this relationship because 
high transmission means higher population sizes of the 
parasite  and  lower  levels  of  inbreeding.  However, 
Orjuela-Sanchéz et al. identified the opposite relationship 
between P. vivax endemicity and genetic diversity: they 
observed the highest levels of diversity in their Sri Lankan 
sample (which came from their area of lowest malaria 
endemicity), and the lowest in their Vietnamese sample 
(which came from their area of highest malaria endemi-
city). Given the aforementioned problems about statis-
tical artifacts in GWAS, such a pattern requires further 
confirmation - but it is certainly an intriguing result.
Second,  their  study’s  investigation  of  mutations  in  a 
known resistance locus found evidence in support of the 
hypothesis  that  chloroquine  resistance  at  that  locus 
requires a two-step mutation process. This has previously 
been suggested by [13] and raises the important possi-
bility  using  detection  of  the  first  mutation  as  an  early 
warning  system  for  the  imminent  emergence  of  drug 
resistance in a vivax population.
It is important to recognize that these are early days in 
the development of a very exciting new technique, and 
that it is not surprising that more questions than answers 
have arisen from its application so far. There are strong 
analogies here to administering a large questionnaire to a 
population and hoping that some clear connections will 
fall out. We know from such experience that patience is 
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nique, and continuous revision of the right questions to 
ask. The pieces of the complex jigsaw may take a long 
time to clink together, and it is crucial that the faith of the 
researchers is located in its long-term outcomes.
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